Stage 0 Non-Small Cell Lung Cancer: Clinical Trials

3 trials for Stage 0 Non-Small Cell Lung Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1
Phase 11Completed 1

Follow Stage 0 Non-Small Cell Lung Cancer: new trials by email Literature Review of Stage 0 Non-Small Cell Lung Cancer trials Research Report on Stage 0 Non-Small Cell Lung Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration - Febrile Neutropenia, Stage 0 Breast Cancer
Not applicableCompletedSWOG Cancer Research Network36652016-10-072022-10-20
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix
Not applicableTerminatedNational Cancer Institute (NCI)302004-05-012013-01-16
Photodynamic Therapy in Treating Patients With Lung Cancer
HPPH, photodynamic therapy, therapeutic bronchoscopy - Adenocarcinoma of the Lung, Large Cell Lung Cancer
Phase 1CompletedRoswell Park Cancer Institute172004-02-012014-07-31

Narrower conditions

Carcinoma, Non-Small-Cell Lung (3)  ·  Adenocarcinoma of Lung (1)  ·  Appendiceal Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Febrile Neutropenia (1)  ·  Gallbladder Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Bronchial Neoplasms (3)  ·  Carcinoma (3)  ·  Carcinoma, Bronchogenic (3)  ·  Lung Diseases (3)  ·  Lung Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Thoracic Neoplasms (3)  ·  Adenocarcinoma (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)

Interventions

1-phenyl-3,3-dimethyltriazene (1)  ·  2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (1)  ·  Photochemotherapy (1)  ·  motexafin lutetium (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (3)  ·  Puerto Rico (1)

Top investigators

Samjot Dhillon (1)  ·  Scott Ramsey (1)  ·  Stephen Michael Hahn (1)

Results publications

PMID 35365139, PMID 36228177, PMID 36279134, PMID 37770704, PMID 37788414

NIH funding

P01CA087971 (1), UG1CA189974 (1)